State Demands FDA Action On Oxycontin

HARTFORD (CN) - More than four years ago, the State of Connecticut asked the U.S. Food and Drug Administration to require Purdue Pharma to put stronger, clearer warnings on Oxycontin labels, warning patients and physicians about the possible results of abusing the drug. The FDA has refused to act, so the State now demands that it do so, in Federal Court.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit